NSE/INDSWFTLAB

INDSWFTLABINDSWFTLAB

NSE Equity · NSE

₹131.86-9.32%

52-wk low52-WEEK RANGE52-wk high

₹70.13+88.0% from low ·-12.3% from high₹150.28

Price chart · 1M–10Y · daily-close

NSE bhavcopy + 10Y historical

INDSWFTLAB+59.42% · 1Y

Range high ₹156.8Range low ₹68.72Latest ₹131.86252 bars · daily-close · NSE bhavcopy + 10Y history

NSE EquityDrug Manufacturers - Specialty & GenericSmallcapLow Risk

Stock scorecard

Auto-computed from latest ratios + sector context · not a buy/sell signal

Composite100/100

Performance

High

Amongst the strong performers in the market.

· 52w return +54.1% — strong momentum
· Trades 26.4% above 200-DMA — uptrend intact

Valuation

Low

Appears to be fairly valued to cheap vs peers.

· P/E 4.1 vs sector median 24.8 — 84% cheaper
· P/B 0.86 below sector median 2.26

Growth

—

Not enough historical data.

Profitability

High

Showing good signs of profitability & efficiency.

· ROE 21.1% — high-quality compounder
· Net margin 6.6% — thin margins

DVM composite · Durability · Valuation · Momentum

Trendlyne-style 3-axis composite · all drivers shown below · not a buy/sell signal

CompositeA+(87/100)

Durability

A+

93/100

Financially resilient — strong quality + solvency profile.

Show 2 drivers

Debt/Equity0.02 (100pt)
ROE21.1% (84pt)

Valuation

A+

100/100

Attractively valued vs peers and growth — good margin of safety.

Show 2 drivers

P/E vs sector (4.1 / 24.8)16% (100pt)
P/B0.86 (100pt)

Momentum

69/100

Constructive setup — momentum building, not extended.

Show 5 drivers

52w change+54.1% (100pt)
DMA-trend alignmentsideways (50pt)
RSI (14)43.8 (35pt)
Price vs 200-DMA+18.9% (98pt)
MACD regimebearish cross (15pt)

Valuation positioning

Current ratio vs sector peer distribution

P/E (TTM)4.07

UNDERVALUED

CheapestP/E 4.1 at 1th %ile of sector — cheaper than 99% of peers.Most expensive

P/B0.86

UNDERVALUED

CheapestP/B 0.86 at 15th %ile of sector.Most expensive

Monthly seasonality

Avg monthly return over 10 years · historical — not a forecast

Best: Jun +13.39% · Worst: Aug -5.83%

Jan

+2.7%

70% win

Feb

-1.6%

30% win

Mar

-5.7%

10% win

Apr

+7.7%

70% win

May

+1.4%

50% win

Jun

+13.4%

Monthly return distribution

Distribution of 120 monthly returns

Mean

+2.31%

Median

-0.06%

Std dev

17.85%

Best

+122.7%

Worst

-42.9%

% positive

50%

SWOT analysis

Auto-derived from ratios + sector context + forensics · research only, not a recommendation

STRENGTHS · 3

High-quality compounder (ROE 21.1%)
Above 20% ROE consistently flags capital-efficient businesses
Lean balance sheet (D/E 0.02)
Low leverage means earnings are less sensitive to rate cycles
Top quartile ROE in Other
Rank 120 of 1000 peers

WEAKNESSES · 0

No material weaknesses flag from the numbers

OPPORTUNITIES · 0

No strong near-term catalysts visible

THREATS · 0

No immediate threats from the data

RETURNS · DAILY-CLOSE BASED

3Y+ shown as CAGR

-9.3%

-6.2%

-4.0%

+44.5%

+35.4%

+58.2%

+30.0%

+11.7%

10Y

+11.3%

Peer	Last close	1Y change	Mcap ₹Cr	P/E	P/B	ROE	D/E	Rev YoY
INDSWFTLABTHIS Ind-Swift Laboratories Limited	₹131.86	+54.1%	1,218	4.1	0.86	21.1%	0.02	—
ABCAPITAL Aditya Birla Capital Limited	₹340.4	+68.1%	89,888	25.8	2.79	10.8%	4.60	+17.6%
ABBOTINDIA Abbott India Limited	₹25,785	-16.6%	54,547	35.8	13.60	38.0%	0.04	+9.6%
360ONE 360 ONE WAM LIMITED	₹1,113.3	+16.7%	44,744	38.7	4.77	12.3%	1.47	+35.0%
3MINDIA 3M India Limited	₹31,410	+4.4%	35,158	92.9	21.83	23.5%	0.06	+6.1%
AADHARHFC Aadhar Housing Finance Limited	₹496.45	+3.5%	21,173	20.8	3.05	14.6%	2.55	—
ABDL Allied Blenders and Distillers Limited	₹573.8	+76.4%	16,176	60.4	10.70	17.7%	0.67	+5.8%
AAVAS Aavas Financiers Limited	₹1,347.9	-37.8%	10,612	17.1	2.26	13.3%	3.08	+13.3%
63MOONS 63 moons technologies limited	₹662.7	-9.8%	8,006	—	0.92	-0.2%	0.00	-6.3%

ASK AXEL

Dig deeper into INDSWFTLAB

Axel can fetch latest news, peer valuation, consensus estimates, insider activity, and concall commentary for INDSWFTLAB — all in one sourced reply.

Ask free in chat

Run these tools on INDSWFTLAB

Historical return →

"If I had bought INDSWFTLAB in year X"

Rolling returns →

Worst/best 1/3/5/7/10-yr windows

Buy-the-dip backtester →

Dip-buying vs SIP on INDSWFTLAB

Brokerage + charges →

All-in cost for trading INDSWFTLAB

Research tool · not investment advice.

Axel Markets is an information + analytics product. We are not a SEBI-registered Research Analyst (RA) or Investment Adviser (IA). Nothing on this page is a buy, sell, or hold recommendation. Past performance is not indicative of future returns. Verify all data against the authoritative source (NSE, BSE, AMFI, SEBI, company RHP / factsheet) before acting. Daily OHLCV sourced primarily from our NSE bhavcopy ingest (public sec_bhavdata_full CSV), with Stooq as a fallback for historical gaps. Split + bonus adjusted. Excludes dividends. Not a recommendation. Past performance does not predict future returns. For authoritative live quotes see NSE / BSE directly.

INDSWFTLABINDSWFTLAB

Price chart · 1M–10Y · daily-close

Stock scorecard

DVM composite · Durability · Valuation · Momentum

Valuation positioning

Monthly seasonality

Monthly return distribution

SWOT analysis

Fundamentals

Peer comparison · Other

Ask Axel about INDSWFTLAB

Recent news

Dig deeper into INDSWFTLAB

Run these tools on INDSWFTLAB

Technical snapshot

Stock scorecard

SWOT analysis

Recent news

DVM composite · Durability · Valuation · Momentum

Valuation positioning

Monthly seasonality

Monthly return distribution

Fundamentals

Pros and cons

Sector-relative context

Company + balance sheet snapshot

Peer comparison · Other